Generation bio to present at the canaccord genuity 44th annual growth conference

Cambridge, mass., aug. 06, 2024 (globe newswire) -- generation bio co.  (nasdaq:gbio) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that geoff mcdonough, m.d., president and chief executive officer, will participate in a fireside chat at the canaccord genuity 44th annual growth conference on tuesday, august 13th, 2024 at 2:30 p.m. et in boston.
GBIO Ratings Summary
GBIO Quant Ranking